{"chunk_type":"transcript_chunk","text":"# Hyperthyroidism Diagnostic Nuance: Lid Lag vs Proptosis + RAIU Logic\n## Key distinction\n- lid lag/stare는 다양한 thyrotoxic state에서 가능.\n- true proptosis/exophthalmos는 Graves orbitopathy를 강하게 시사.\n\n## Diagnostic flow\n- low TSH + high free hormone 확인 후 원인 분류.\n- 임상적으로 Graves가 명확하지 않으면 RAIU로 과생산 vs 누출/외인성 상태를 구분.\n\n## RAIU interpretation table\n| 패턴 | RAIU | 대표 상황 | 치료 포인트 |\n| --- | --- | --- | --- |\n| Factory overproduction | 높음 | Graves, toxic adenoma/multinodular goiter | thionamide/definitive therapy 고려 |\n| Leak/factitious | 낮음 | thyroiditis, exogenous hormone, struma ovarii | methimazole 효과 제한, 대증치료 중심 |","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-241","focus_area":"Hyperthyroidism RAIU Nuance","tags":["usmle-step2","endocrinology","thyroid","diagnosis","table"]}
{"chunk_type":"transcript_chunk","text":"# Hyperthyroidism Treatment and Thyroiditis Subtypes\n## Hyperthyroidism treatment\n- methimazole이 기본이지만 agranulocytosis warning symptom(발열/인후통) 교육 필수.\n- 임신 1분기는 PTU, 이후 methimazole 전환.\n- 중등도 이상 ophthalmopathy에서는 radioiodine 전략을 신중히 선택.\n\n## Thyroid storm clue\n- 고열 + 정신상태 변화 + severe thyrotoxicosis 맥락은 응급 다중치료 필요.\n\n## Thyroiditis profile\n- painless/silent, subacute(painful, ESR/CRP 상승), postpartum를 구분.\n- postpartum에서 Graves와 감별이 필요하면 적절한 항체/임상 맥락 활용.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-261","focus_area":"Hyperthyroidism Treatment and Thyroiditis","tags":["usmle-step2","endocrinology","thyroid","treatment","pregnancy"]}
{"chunk_type":"transcript_chunk","text":"# Thyroid Gray-zone Algorithms: Nodule, Subclinical, Euthyroid Sick\n## Thyroid nodule sequence\n1. TSH first.\n2. low TSH면 scintigraphy branch.\n3. normal/high TSH면 ultrasound risk stratification 후 FNA.\n\n## Subclinical hypothyroidism\n- TSH level, 증상, 임신 계획, 연령에 따라 치료/관찰을 분기.\n\n## Euthyroid sick syndrome\n- critical illness에서 발생하는 adaptive pattern으로, thyroid hormone routine replacement를 피하고 기저질환 치료에 집중.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-281","focus_area":"Thyroid Gray-zone Algorithms","tags":["usmle-step2","endocrinology","thyroid-nodule","diagnosis"]}
{"chunk_type":"recap_summary","text":"# Thyroid Rapid Recap\n- hyperthyroidism은 원인분류(과생산 vs 누출)를 먼저 결정.\n- thyroid storm은 fever/neurologic change 동반 시 즉시 응급치료.\n- 임신에서는 trimester별 항갑상선제 전략과 hypothyroid dose-up 타이밍이 핵심.\n- nodule은 TSH-first, euthyroid sick syndrome은 과치료 금지.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-294","focus_area":"Thyroid Rapid Recap","tags":["usmle-step2","endocrinology","recap","thyroid"]}
{"chunk_type":"transcript_chunk","text":"# Hypertension Framework: Physiology + Measurement Strategy\n## Physiology lens\n- diastolic pressure는 SVR, pulse pressure는 stroke volume/arterial compliance를 반영.\n- 고령 isolated systolic HTN은 arterial stiffness와 연결.\n\n## Confirming diagnosis\n- office BP 단독보다 ambulatory/home BP가 실제 burden을 더 잘 반영.\n- white-coat/masked HTN을 반드시 고려.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-1","focus_area":"Hypertension Physiology and Diagnosis","tags":["usmle-step2","cardiology","hypertension","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# Hypertension Treatment Staging + Lifestyle + Comorbidity-tailored Drug Choice\n## Treatment staging\n- stage 1은 global risk 동반 여부로 lifestyle-only vs medication 병행을 분기.\n- stage 2는 보통 약물 치료를 조기 시작.\n\n## Decision table\n| 단계 | 환자 특성 | 기본 전략 |\n| --- | --- | --- |\n| Stage 1 | 낮은 ASCVD risk | lifestyle 우선 |\n| Stage 1 | 고위험(DM/CKD/ASCVD risk 상승) | lifestyle + 약물 |\n| Stage 2 | 위험도와 무관하게 고혈압 지속 | 약물 포함 적극 치료 |\n\n## Comorbidity-based selection\n- post-MI/HFrEF: ACEi/ARB + beta-blocker.\n- gout: losartan 선호, thiazide 주의.\n- osteoporosis: thiazide 이점 고려.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-21","focus_area":"Hypertension Treatment and Comorbidity","tags":["usmle-step2","cardiology","hypertension","treatment","table"]}
{"chunk_type":"transcript_chunk","text":"# Secondary Hypertension Clues + Hypertensive Crisis Triage\n## Secondary clues\n- abdominal bruit/ACEi 후 Cr 상승/flash pulmonary edema -> renovascular HTN.\n- hypokalemic metabolic alkalosis -> primary aldosteronism.\n- episodic headache-palpitations-sweating -> pheochromocytoma.\n- arm-leg BP gradient -> coarctation.\n\n## Crisis table\n| 구분 | End-organ damage | 치료 접근 |\n| --- | --- | --- |\n| Hypertensive urgency | 없음 | 경구제 + 점진적 조절 |\n| Hypertensive emergency | 있음(뇌/심장/신장/망막) | IV 약제 + 모니터링 하 신속 조절 |","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-41","focus_area":"Secondary HTN and Crisis","tags":["usmle-step2","cardiology","secondary-hypertension","emergency","table"]}
{"chunk_type":"recap_summary","text":"# Hypertension Recap + Transition to IE/RHD\n## Rapid recap\n1. 고혈압 치료는 수치+위험도+동반질환을 같이 본다.\n2. 생활습관 중 체중감량/DASH는 BP 자체를 유의미하게 낮춘다.\n3. secondary HTN 단서가 있으면 원인평가를 우선.\n4. emergency는 장기손상 유무로 정의.\n\n## Transition\n- 다음 블록은 infective endocarditis와 rheumatic disease의 감염 vs 면역 기전 분리에 초점을 둔다.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-51","focus_area":"Hypertension Recap and IE Transition","tags":["usmle-step2","cardiology","hypertension","recap"]}
{"chunk_type":"transcript_chunk","text":"# Infective Endocarditis Core: Risk, Signs, and Etiologic Pattern\n## Major risk settings\n- prosthetic valve, prior IE, IVDU, intravascular access가 고위험.\n\n## Clinical signs and mechanism\n| 소견 | 임상 특징 | 기전 |\n| --- | --- | --- |\n| Janeway lesions | 통증 없는 손발바닥 병변 | septic microemboli |\n| Osler nodes | 통증 있는 결절 | immune complex-mediated |\n| Roth spots/splinter hemorrhage | 혈관성 미세병변 | 염증/미세색전 연관 |\n\n## Etiology cues\n- IVDU는 right-sided IE(tricuspid)와 pulmonary septic emboli를 동반할 수 있음.\n- 특정 균주 단서(예: S. gallolyticus)에서는 연관 장기 평가(예: colon pathology)를 연결.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-61","focus_area":"Infective Endocarditis Core","tags":["usmle-step2","cardiology","infective-endocarditis","diagnosis","table"]}
{"chunk_type":"transcript_chunk","text":"# IE Management + Prophylaxis + RHD Introduction\n## IE management\n- 반복 blood culture + echo(필요 시 TEE)로 확진 경로를 밟는다.\n- hemodynamic instability, heart failure, uncontrolled infection, embolic risk에서 수술 적응증 고려.\n\n## Prophylaxis boundaries\n- prophylaxis는 고위험 cardiac group + 고위험 시술에 제한적으로 적용.\n- 저위험군에는 불필요한 항생제 예방을 피한다.\n\n## RHD transition\n- ARF/RHD는 감염 자체가 아닌 post-streptococcal immune mechanism으로 이해.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-81","focus_area":"IE Management and RHD Entry","tags":["usmle-step2","cardiology","infective-endocarditis","treatment","prophylaxis"]}
{"chunk_type":"transcript_chunk","text":"# Rheumatic Heart Disease: Jones Logic + Secondary Prevention\n## Core mechanism\n- untreated GAS pharyngitis 이후 molecular mimicry로 다기관 염증이 발생.\n- Jones criteria를 임상 시나리오와 연결해 해석.\n\n## Long-term course\n- 반복 염증 후 만성 판막 손상(특히 mitral pathology)로 진행.\n\n## Secondary prophylaxis table\n| 임상군 | 페니실린 2차 예방 기간 개념 |\n| --- | --- |\n| carditis 없음 | 단기-중기 예방 |\n| carditis 있으나 잔여판막 손상 없음 | 더 긴 예방 |\n| carditis + 잔여 판막질환 | 장기/평생 예방 고려 |","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-101","focus_area":"RHD Prevention Framework","tags":["usmle-step2","cardiology","rheumatic-heart-disease","prevention","table"]}
{"chunk_type":"transcript_chunk","text":"# Cholesterol Crystal Embolism + Statin Indication Framework\n## Cholesterol embolism\n- 혈관 시술 후 피부허혈/AKI/eosinophilia 조합에서 의심.\n- 생검의 cholesterol cleft 소견이 진단 지지.\n- 급성기 특효약보다 supportive care + plaque stabilization 전략이 중심.\n\n## Statin 4-group framework\n| 그룹 | 기준 | 전략 |\n| --- | --- | --- |\n| Secondary prevention | established ASCVD | statin 필수(강도는 연령/내약성 반영) |\n| Severe LDL elevation | LDL ≥ 190 | 고강도 statin 우선 |\n| Diabetes age-range | 40-75 + diabetes | 최소 중강도 이상 고려 |\n| Elevated primary risk | 40-75, no DM, risk 상승 | 위험도 기반 statin 도입 |","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-121","focus_area":"Cholesterol Embolism and Statin Groups","tags":["usmle-step2","cardiology","lipids","statin","table"]}
{"chunk_type":"transcript_chunk","text":"# Hypertriglyceridemia Priorities + ACS Statin Role + Lifestyle\n## TG priority\n- 매우 높은 TG에서는 ASCVD보다 급성 췌장염 예방이 immediate goal.\n- fibrate/omega-3/금주/체중감량을 적극 적용.\n\n## ACS context\n- ACS 급성기 고용량 statin은 lipid lowering뿐 아니라 plaque stabilization/anti-inflammatory 효과가 핵심.\n\n## Lifestyle backbone\n- Mediterranean/DASH pattern, 금주, 체중감량, 운동을 약물치료와 병행.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-141","focus_area":"Triglyceride and ACS Lipid Strategy","tags":["usmle-step2","cardiology","triglyceride","acs","treatment"]}
{"chunk_type":"recap_summary","text":"# Lipid Rapid Recap + Transition to Aorta/Carotid Disease\n## Rapid recap\n- procedure 후 blue toe + AKI + eosinophilia는 cholesterol embolism red flag.\n- statin 적응증은 4-group으로 구조화.\n- severe TG는 pancreatitis prevention을 최우선.\n- ACS에서는 초기 고강도 statin을 지연하지 않는다.\n\n## Transition\n- 다음은 대동맥/경동맥 질환을 dissection, aneurysm, occlusion 패턴으로 구분.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-151","focus_area":"Lipid Recap and Aorta Transition","tags":["usmle-step2","cardiology","lipid","recap"]}
{"chunk_type":"transcript_chunk","text":"# Aortic Dissection and AAA Framework\n## Aortic dissection\n- tearing chest/back pain + risk factors(HTN/connective tissue disease)에서 의심.\n- pulse deficit 부재가 배제를 의미하지 않는다.\n\n## Imaging choice table\n| 환자 상태 | 우선 검사 | 이유 |\n| --- | --- | --- |\n| Hemodynamically unstable | Bedside TEE | 즉시 확인 및 치료 결정 가능 |\n| Hemodynamically stable | CT angiography | 해부학적 범위 평가에 유리 |\n\n## AAA\n- rupture suspicion(복통+저혈압) 시 즉시 수술 경로.\n- 안정 환자는 크기/성장속도/증상으로 수술 시점을 결정.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-161","focus_area":"Aortic Dissection and AAA","tags":["usmle-step2","cardiology","aortic-dissection","aaa","emergency"]}
{"chunk_type":"transcript_chunk","text":"# AAA Size-based Management + Coarctation + Leriche Syndrome\n## AAA management table\n| 상황 | 관리 |\n| --- | --- |\n| ruptured or impending rupture | 즉시 수술/응급처치 |\n| >5.5 cm 또는 rapid expansion 또는 symptomatic | elective repair 고려 |\n| 중간 크기, 무증상 | 주기적 영상 추적 |\n\n## Coarctation clues\n- arm>leg BP, radio-femoral delay, rib notching.\n- neonatal critical case에서 ductal patency 유지(PGE1) 필요.\n\n## Leriche triad\n- buttock claudication + erectile dysfunction + diminished femoral pulses.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-181","focus_area":"AAA Coarctation Leriche","tags":["usmle-step2","cardiology","aaa","coarctation","leriche","table"]}
{"chunk_type":"transcript_chunk","text":"# Carotid Stenosis/Dissection: Stroke Prevention Strategy\n## Carotid stenosis intervention table\n| 환자군 | 협착 정도/조건 | 접근 |\n| --- | --- | --- |\n| Symptomatic | 고도 협착 | CEA 적극 고려 |\n| Asymptomatic | 매우 고도 협착에서 선택적 | 대개 medical therapy 우선 |\n| All | risk factor control | antiplatelet/statin/BP control |\n\n## Carotid dissection\n- neck trauma/rotation 이후 focal neuro deficit + partial Horner pattern이 단서.\n- CTA 진단 후 antithrombotic strategy로 embolic stroke 예방.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-201","focus_area":"Carotid Stenosis and Dissection","tags":["usmle-step2","cardiology","carotid-stenosis","carotid-dissection","stroke","table"]}
{"chunk_type":"recap_summary","text":"# Aorta-Carotid Rapid Fire Recap\n1. dissection: unstable=TEE, stable=CTA.\n2. AAA rupture suspicion은 imaging 지연보다 OR pathway 우선.\n3. coarctation은 upper-lower pressure gradient와 collateral signs로 진단.\n4. Leriche는 aortoiliac occlusive triad로 인식.\n5. carotid stenosis는 증상 여부 + 협착률로 CEA 적응증 결정.\n6. carotid dissection은 trauma/neck movement history와 neurologic deficit를 연결.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-215","focus_area":"Aorta Carotid Rapid Recap","tags":["usmle-step2","cardiology","recap","vascular"]}
